| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 82.77 | 0.54 (+0.66%) | 59.14 - 90.42 | 1.1 million |
Market data as of 4:01PM 05/16/12. Quotes are delayed by at least 15 min.
| Open | 82.35 |
|---|---|
| Previous Close | 82.23 |
| Day's Range | 82.00 - 83.41 |
| Market Cap | 7.8B |
| Avg Volume (10 Day) | 1.1M |
| Price/Earnings (Trailing 12 Mo.) | 15.0x |
| Earnings Per Share (Trailing 12 Mo.) | 5.5 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
DaVita to Present 13 Abstracts at the National Kidney Foundation’s 2012 Spring Clinical Meeting
Business Wire - Thursday 05/10/2012 6:00 AM ET
Sixth Annual Tour DaVita Coming to Iowa
Business Wire - Monday 05/07/2012 12:27 PM ET
DaVita 1st Quarter 2012 Results
Business Wire - Tuesday 05/01/2012 7:40 PM ET
DaVita Inc. Schedules 1st Quarter 2012 Investor Conference Call
Business Wire - Thursday 04/19/2012 6:00 PM ET
DaVita® Named to WorldBlu List of Most Democratic Workplaces
Business Wire - Tuesday 04/17/2012 7:00 AM ET
DaVita Announces CFO Transition
Business Wire - Monday 04/16/2012 2:01 AM ET
| DVA | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 11.62% | |
| Net Income Growth (1yr) | 54.28% | |
| Total Debt/Equity | 1.97 | |
| LT Debt/Equity | 1.94 | |
| Earnings Yield | 6.67% | |
| Price/Sales | 1.07 |
| Company | Last | Change |
|---|---|---|
| MEDNAX Inc | 63.66 | -0.33% |
| Healthsouth Corp | 20.14 | -1.18% |
| Hanger Orthopedic Group Inc | 22.25 | -0.80% |
| IPC The Hospitalist Company Inc | 34.72 | -1.17% |
| Nordion Inc | 8.88 | +1.49% |
Data is delayed by at least 15 min.